Bioengineering for Cell and Immuno Delivery

The newly merged Bioengineering for Cell and Immuno Delivery (BCID) Focus Group brings together researchers and professionals across academia and industry to advance innovative approaches to therapeutic delivery.

BCID is a dynamic community for cutting-edge science, collaboration, career development, and translational impact—connecting ideas and people to accelerate the future of bioengineering and immuno delivery.

Computation in Drug Delivery

Computation in Drug Delivery Focus Group brings together researchers from academia and industry to explore how computational methods, modeling, and machine learning are shaping the future of drug delivery research. In 2026–2027, the group will foster scientific exchange, member engagement, and knowledge sharing through webinars, quarterly CRS newsletter articles, and conversations with academic and industry experts. Activities will spotlight emerging computational applications across oral drug delivery, nucleic acid therapeutics, long-acting injectables, microfluidic systems, and beyond

Nanoscale Delivery & Genetic Therapeutics

The Nanoscale Delivery and Genetic Therapeutics (NDGT) Focus Group brings together researchers, industry scientists, regulatory experts, and emerging professionals advancing nanoscale delivery and genetic medicines. Explore innovations in nanocarriers, nucleic acids, gene editing, targeting, formulation, and translation while connecting with a multidisciplinary community shaping the future of therapeutic delivery.

Ocular Delivery Focus Group

Ocular Delivery Focus Group brings together researchers, industry leaders, and regulatory experts advancing innovative drug delivery technologies to protect and restore vision. From controlled-release systems to next-generation ocular therapeutics, the group collaboration and knowledge sharing to accelerate safer, more effective treatments for eye diseases.

Oral Delivery Focus Group

Oral Delivery Focus Group brings together researchers and professionals advancing oral drug delivery—from improving the bioavailability of small molecules to developing oral delivery systems for proteins and nucleic acids. The group connects members across academia, industry, regulatory agencies, and other sectors to share innovations in dosage forms, controlled release, targeting, and gastrointestinal drug transport.

Skin and Mucosal Delivery (SMD) Focus Group connects scientists and professionals across academia, industry, and government to advance delivery science across skin and mucosal barriers. The group fosters collaboration, networking, idea exchange, and professional development while increasing member visibility and engagement within CRS.

Smart & Functional Healthcare Materials Focus Group brings together researchers from academia, industry, and the early-career community to explore emerging materials and technologies for healthcare and drug delivery. Through webinars, articles, social media, and early-career initiatives, the group promotes education, collaboration, and knowledge sharing across the CRS community.

Women’s Health and Sex-Specific Differences in Delivery Science Focus Group brings together researchers, clinicians, engineers, industry experts, regulators, entrepreneurs, and trainees to advance innovative drug delivery and translational research in women’s health. The group focuses on addressing unmet needs across the lifespan, including reproductive health, pregnancy, gynecologic disease, cancer, menopause, and healthy aging, while fostering collaboration and accelerating the translation of new technologies into clinical practice.